Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

LEVOFLOXACIN IN 5% DEXTROSE INJECTION DIN 02460122

Status: Approved
Holder: STERIMAX INC
Molecule: LEVOFLOXACIN

Health Canada record

Active ingredient(s)LEVOFLOXACIN 5 MG
Dosage formSolution
RouteIntravenous
SchedulePRESCRIPTION
ClassHuman
ATCJ01MA12 LEVOFLOXACIN
Original market date
Current status date22-Dec-2016
SourceHealth Canada DPD

Establishment licence of the holder

Sterimax Inc — licence 100925, currently licensed, last inspection rating C (2024-05-13).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing LEVOFLOXACIN

DINProductCompanyFormStrengthStatus
02537079LEVOFLOXACIN IN 5% DEXTROSE INJECTIONHIKMA CANADA LIMITEDSolutionLEVOFLOXACIN 5 MGMarketed
02314932LEVOFLOXACIN IN 5% DEXTROSE INJECTIONPFIZER CANADA ULCSolutionLEVOFLOXACIN 5 MGMarketed
02361035AVA-LEVOFLOXACINAVANSTRA INCTabletLEVOFLOXACIN 500 MGCancelled Post Market
02361027AVA-LEVOFLOXACINAVANSTRA INCTabletLEVOFLOXACIN 250 MGCancelled Post Market
02236841LEVAQUINJANSSEN INCTabletLEVOFLOXACIN 250 MGCancelled Post Market
02236840LEVAQUIN 25MG/MLJANSSEN INCSolutionLEVOFLOXACIN 25 MGCancelled Post Market
02236842LEVAQUIN 500MGJANSSEN INCTabletLEVOFLOXACIN 500 MGCancelled Post Market
02236839LEVAQUIN 5MG/MLJANSSEN INCSolutionLEVOFLOXACIN 5 MGCancelled Post Market
02246804LEVAQUIN 750MGJANSSEN INCTabletLEVOFLOXACIN 750 MGCancelled Post Market
02358670NTP-LEVOFLOXACINTEVA CANADA LIMITEDTabletLEVOFLOXACIN 750 MGCancelled Pre Market
02358662NTP-LEVOFLOXACINTEVA CANADA LIMITEDTabletLEVOFLOXACIN 500 MGCancelled Pre Market
02358654NTP-LEVOFLOXACINTEVA CANADA LIMITEDTabletLEVOFLOXACIN 250 MGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
188052016-12-22Abbreviated New Drug Submission (ANDS)

International API supply for LEVOFLOXACIN

23 active FDA Drug Master Files.

Request a quote for LEVOFLOXACIN IN 5% DEXTROSE INJECTION

How to read a Canadian DIN record